Your fact-checks will appear here
For-profit health care company
The seven largest publicly traded U.S. health insurers’ chief executives earned roughly $146 million in combined total compensation in 2024, according to multiple industry analyses of companies’ SEC p...
Optum is the healthcare services arm of UnitedHealth Group, formed in 2011 and now a vast business spanning pharmacy, analytics and direct care; UnitedHealth/Optum have completed multibillion-dollar d...
UnitedHealth Group is a publicly traded corporation owned by its shareholders, with ownership dominated by large institutional investors; the single largest reported holder is The Vanguard Group, foll...
Available reporting and product pages indicate Neurocept is marketed primarily through its own “official” websites and third‑party review/affiliate pages; multiple sources state it is “exclusively” or...
UnitedHealth Group is a publicly traded corporation whose shares are widely held by institutional investors (about 80%–81% per market-data sites) with a small portion held by company insiders and reta...
Vanguard and BlackRock together control roughly 16–19% of UnitedHealth Group through beneficial ownership stakes, with Vanguard holding about 9% and BlackRock roughly 7.8–8.2% depending on the data sn...
Federal and state regulators have opened multiple probes and lawsuits touching Optum’s national footprint: the U.S. Department of Justice launched an antitrust investigation into UnitedHealth/Optum’s ...
Gavin Newsom’s public and legal responses to major financial-misconduct allegations have consisted mainly of a stippled legal settlement paying a $13,000 fine for late reporting of charitable payments...
Available reporting does not show a direct business relationship between Dr. Mehmet Oz and Karyopharm Therapeutics (commonly shortened to “Karyopharm” or “karylief”) in the provided sources. The sourc...
Dr. Mehmet Oz has disclosed advisory and investment ties to supplement seller iHerb and said he will divest or resign from certain roles if confirmed as CMS administrator; his ethics filing and subseq...
Available reporting shows insurers deny a substantial share of post-service claims—about 19% of in‑network claims in ACA Marketplace plans in 2023—and surveys and other analyses find patients experien...
A targeted review of credible news coverage from 2023 through 2025 finds Major outlets that examined Oz’s investments and potential conflicts of interest catalogued holdings in health insurers, pharma...
Dr. Mehmet Oz’s public financial disclosures and reporting show he and his wife have owned stock in pharmaceutical companies, including Johnson & Johnson and others, but the records cited do not docum...